HALO Next Earnings Date Notes

— Halozyme Therapeutics (HALO) is a biotechnology company specializing in novel drug delivery and specialty oncology therapies, notably through its ENHANZE® drug delivery platform, which leverages a recombinant human hyaluronidase enzyme (rHuPH20) to boost the efficacy & convenience of subcutaneous drug administration. Rather than focusing solely on developing its own large portfolio of drugs, Halozyme monetizes its proprietary technology by entering into licensing & collaboration agreements with major pharmaceutical partners, who utilize ENHANZE® to enhance established intravenous drugs and convert them into subcutaneous formulations. For investors tuning in to the next HALO earnings call, it is crucial to track royalty & milestone revenues as key financial drivers, as these are directly tied to commercial successes by partners such as Roche, Pfizer, and Johnson & Johnson. Additionally, monitoring updates on new collaboration agreements, clinical pipeline progress, and any expansion of ENHANZE® applications will provide insights into long-term growth potential. Other important business metrics include operating margin, cash flow generation, and any guidance changes for both revenue and earnings per share (EPS), as these reflect the health & leverage of Halozyme’s highly scalable, partnership-based business model. The next projected earnings date for HALO is 11/2/2026 after close (stay tuned for a confirmed earnings date once announced).

HALO Next Earnings Date FAQ

On this page we presented the HALO Next Earnings Date information for Halozyme Therapeutics along with recent past earnings dates. For Q2 of 2026, HALO reported earnings of 2.280/share, with the earnings report taking place on 8/6/2026. For Q1 of 2026, HALO reported earnings of 1.600/share, with the earnings report taking place on 5/11/2026. For Q4 of 2025, HALO reported earnings of -0.240/share, with the earnings report taking place on 2/17/2026. For Q3 of 2025, HALO reported earnings of 1.720/share, with the earnings report taking place on 11/3/2025. For Q2 of 2025, HALO reported earnings of 1.540/share, with the earnings report taking place on 8/5/2025. Based on these past earnings dates, the projected next earnings date for HALO is 11/2/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Halozyme Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Halozyme Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Halozyme Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next HALO earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up HALO's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the HALO next earnings date.